AAAAAA

   
Results: 1-25 | 26-38 |
Results: 26-38/38
IMMUNIZATIONS AFTER BONE-MARROW TRANSPLANTATION - RESULTS OF A EUROPEAN SURVEY AND RECOMMENDATIONS FROM THE INFECTIOUS-DISEASES WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION
Authors: LJUNGMAN P CORDONNIER C DEBOCK R EINSELE H ENGELHARD D GRUNDY J LINK H LOCASCIULLI A PRENTICE G REUSSER P RIBAUD P
Citation: P. Ljungman et al., IMMUNIZATIONS AFTER BONE-MARROW TRANSPLANTATION - RESULTS OF A EUROPEAN SURVEY AND RECOMMENDATIONS FROM THE INFECTIOUS-DISEASES WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, Bone marrow transplantation, 15(3), 1995, pp. 455-460
MR OF CEREBRAL ASPERGILLOSIS IN PATIENTS WHO HAVE HAD BONE-MARROW TRANSPLANTATION
Authors: MIAUX Y RIBAUD P WILLIAMS M GUERMAZI A GLUCKMAN E BROCHERIOU C LAVALJEANTET M
Citation: Y. Miaux et al., MR OF CEREBRAL ASPERGILLOSIS IN PATIENTS WHO HAVE HAD BONE-MARROW TRANSPLANTATION, American journal of neuroradiology, 16(3), 1995, pp. 555-562
INVASIVE ASPERGILLOSIS (IA) AFTER ALLOGENEIC MARROW TRANSPLANTATION -SURVIVAL, PROGNOSTIC FACTORS AND MOLECULAR EPIDEMIOLOGY IN 27 CASES OBSERVED IN A SINGLE-CENTER
Authors: RIBAUD P CHASTANG CI LATGE JP SERFATI J BAFFROYLAFITTE L PARQUET N DEVERGIE A ESPEROU H SOCIE G TRAORE F BOUAKLINE A GLUCKMAN E
Citation: P. Ribaud et al., INVASIVE ASPERGILLOSIS (IA) AFTER ALLOGENEIC MARROW TRANSPLANTATION -SURVIVAL, PROGNOSTIC FACTORS AND MOLECULAR EPIDEMIOLOGY IN 27 CASES OBSERVED IN A SINGLE-CENTER, Blood, 86(10), 1995, pp. 843-843
PLACENTAL CORD-BLOOD BANKING AND TRANSPLANT
Authors: GLUCKMAN E TRAINEAU R BROSSARD U DALCORTIVO L DEVERGIE A RIBAUD P ESPEROU H SOCIE G PARQUET N
Citation: E. Gluckman et al., PLACENTAL CORD-BLOOD BANKING AND TRANSPLANT, Blood, 86(10), 1995, pp. 1546-1546
INVASIVE ASPERGILLOSIS AND ALLOGENEIC BON E-MARROW TRANSPLANTATION
Authors: RIBAUD P ESPEROUBOURDEAU H DEVERGIE A GLUCKMAN E
Citation: P. Ribaud et al., INVASIVE ASPERGILLOSIS AND ALLOGENEIC BON E-MARROW TRANSPLANTATION, Pathologie et biologie, 42(7), 1994, pp. 652-655
IMPACT OF LIVER-DISEASE AND HEPATITIS INFECTIONS ON ALLOGENEIC BONE-MARROW TRANSPLANTATION IN EUROPE - A SURVEY FROM THE EUROPEAN BONE-MARROW TRANSPLANTATION (EBMT) GROUP INFECTIOUS-DISEASES WORKING PARTY
Authors: LOCASCIULLI A ALBERTI A DEBOCK R CORDONNIER C EINSELE H ENGELHARD D GRUNDY J REUSSER P RIBAUD P LJUNGMAN P
Citation: A. Locasciulli et al., IMPACT OF LIVER-DISEASE AND HEPATITIS INFECTIONS ON ALLOGENEIC BONE-MARROW TRANSPLANTATION IN EUROPE - A SURVEY FROM THE EUROPEAN BONE-MARROW TRANSPLANTATION (EBMT) GROUP INFECTIOUS-DISEASES WORKING PARTY, Bone marrow transplantation, 14(5), 1994, pp. 833-837
PROPHYLAXIS OF TOXOPLASMOSIS INFECTION WITH PYRIMETHAMINE SULFADOXINE(FANSIDAR) IN BONE-MARROW TRANSPLANT RECIPIENTS/
Authors: FOOT ABM GARIN YJF RIBAUD P DEVERGIE A DEROUIN F GLUCKMAN E
Citation: Abm. Foot et al., PROPHYLAXIS OF TOXOPLASMOSIS INFECTION WITH PYRIMETHAMINE SULFADOXINE(FANSIDAR) IN BONE-MARROW TRANSPLANT RECIPIENTS/, Bone marrow transplantation, 14(2), 1994, pp. 241-245
MALIGNANT DISEASES AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - AN UPDATED OVERVIEW
Authors: SOCIE G HENRYAMAR M DEVERGIE A ESPEROUBOURDEAU H RIBAUD P TRAINEAU R GLUCKMAN E
Citation: G. Socie et al., MALIGNANT DISEASES AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - AN UPDATED OVERVIEW, Nouvelle revue francaise d'hematologie, 36, 1994, pp. 190000075-190000077
PROGRESS IN THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: DEVERGIE A TRAINEAU R ESPEROUBOURDEAU H RIBAUD P SOCIE G RICHARD P SELIMI F HIRSCH I GLUCKMAN E
Citation: A. Devergie et al., PROGRESS IN THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Nouvelle revue francaise d'hematologie, 36, 1994, pp. 190000089-190000090
AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - CLINICAL FINDINGS, INCIDENCE AND RISK-FACTORS
Authors: SOCIE G SELIMI F SEDEL L FRIJA J DEVERGIE A BOURDEAU HE RIBAUD P GLUCKMAN E
Citation: G. Socie et al., AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - CLINICAL FINDINGS, INCIDENCE AND RISK-FACTORS, British Journal of Haematology, 86(3), 1994, pp. 624-628
PRACTICES FOR CYTOMEGALOVIRUS DIAGNOSIS, PROPHYLAXIS AND TREATMENT INALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS - A REPORT FROM THE WORKING PARTY FOR INFECTIOUS-DISEASES OF THE EBMT
Authors: LJUNGMAN P DEBOCK R CORDONNIER C EINSELE H ENGELHARD D GRUNDY J LOCASCIULLI A REUSSER P RIBAUD P
Citation: P. Ljungman et al., PRACTICES FOR CYTOMEGALOVIRUS DIAGNOSIS, PROPHYLAXIS AND TREATMENT INALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS - A REPORT FROM THE WORKING PARTY FOR INFECTIOUS-DISEASES OF THE EBMT, Bone marrow transplantation, 12(4), 1993, pp. 399-403
EPIDEMIOLOGY AND DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS IN BONE-MARROW TRANSPLANT PATIENTS - RESULTS OF A 5-YEAR RETROSPECTIVE STUDY
Authors: SAUGIERVEBER P DEVERGIE A SULAHIAN A RIBAUD P TRAORE F BOURDEAUESPEROU H GLUCKMAN E DEROUIN F
Citation: P. Saugierveber et al., EPIDEMIOLOGY AND DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS IN BONE-MARROW TRANSPLANT PATIENTS - RESULTS OF A 5-YEAR RETROSPECTIVE STUDY, Bone marrow transplantation, 12(2), 1993, pp. 121-124
INFLUENCE OF VARIOUS CONDITIONING REGIMENS ON THE OUTCOME OF BONE-MARROW TRANSPLANTATION FOR LEUKEMIA
Authors: DEVERGIE A SOCIE G ESPEROUBOURDEAU H RIBAUD P TRAINEAU R GLUCKMAN E
Citation: A. Devergie et al., INFLUENCE OF VARIOUS CONDITIONING REGIMENS ON THE OUTCOME OF BONE-MARROW TRANSPLANTATION FOR LEUKEMIA, Nouvelle revue francaise d'hematologie, 33(6), 1991, pp. 437-439
Risultati: 1-25 | 26-38 |